Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Non Operating Interest Expenses (2021 - 2026)

Updated

Valion Bio (VBIO) recorded Non Operating Interest Expenses of $691,000 in Q2 2026.

Analysis

Valion Bio (VBIO) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

On a TTM basis, Valion Bio's Non Operating Interest Expenses came in at $1.19 million as of Jun 30, 2026; for FY2025, it was $146,000.

  • The Q2 2026 figure is the lowest quarterly Non Operating Interest Expenses since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 217.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 435.00 Mn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 247.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Valion Bio 125,763.04 -19.31 Mn - 691,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 691,000.00
Jun 30, 2021 223,000.00
Mar 31, 2021 274,000.00
API Access

Valion Bio Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEY